Beta Bionics, Inc. Common Stock (BBNX) — Net Asset Momentum
Beta Bionics, Inc. Common Stock (BBNX) recorded a net asset momentum of 280.4% as of December 2025, with net assets of $289.16 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Beta Bionics, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Beta Bionics, Inc. Common Stock Net Asset Momentum (2022–2025)
This chart tracks Beta Bionics, Inc. Common Stock's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +280.4%, with net assets of $289.16 Million USD as of December 2025. Read Beta Bionics, Inc. Common Stock total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Beta Bionics, Inc. Common Stock (2022–2025)
The table below shows the complete annual net asset history for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of Beta Bionics, Inc. Common Stock.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $289.16 Million | $328.74 Million | $39.59 Million | ▲ +280.4% |
| 2024 | $76.01 Million | $149.65 Million | $73.63 Million | ▲ +29.7% |
| 2023 | $58.61 Million | $110.04 Million | $51.43 Million | ▲ +350.8% |
| 2022 | $13.00 Million | $35.53 Million | $22.53 Million | — |